Cargando…
A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
BACKGROUND: Triple-negative breast cancer (TNBC) is an aggressive cancer with unfavorable outcome and it is useful to explore noninvasive biomarkers for its early diagnosis. Here, we identified differentially expressed long noncoding RNAs (lncRNAs) in blood samples of patients with TNBC to assess th...
Autores principales: | Liu, Man, Xing, Lu-Qi, Liu, Yi-Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340452/ https://www.ncbi.nlm.nih.gov/pubmed/28248879 http://dx.doi.org/10.1097/MD.0000000000006222 |
Ejemplares similares
-
Trends of triple negative breast cancer research (2007–2015): A bibliometric study
por: Wang, Yiran, et al.
Publicado: (2016) -
Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
por: Aydiner, Adnan, et al.
Publicado: (2015) -
MRI-based radiomics approach for the prediction of recurrence-free survival in triple-negative breast cancer after breast-conserving surgery or mastectomy
por: Zhao, Jingwei, et al.
Publicado: (2023) -
Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets
por: Wang, Xiaosheng, et al.
Publicado: (2016) -
Vinorelbine Plus Platinum in Patients with Metastatic Triple Negative Breast Cancer and Prior Anthracycline and Taxane Treatment
por: li, Meiying, et al.
Publicado: (2015)